Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy)

BACKGROUND: Advanced pancreatic cancer, in addition to its high mortality, is characterized by one of the highest rates of venous thromboembolic events (VTE) as compared to other types of cancer. Enoxaparin, a low molecular weight heparin (LMWH), has proven to be effective for the prevention and tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Riess, Hanno, Pelzer, Uwe, Hilbig, Andreas, Stieler, Jens, Opitz, Bernhard, Scholten, Theo, Kauschat-Brüning, Dörte, Bramlage, Peter, Dörken, Bernd, Oettle, Helmut
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613915/
https://www.ncbi.nlm.nih.gov/pubmed/19055847
http://dx.doi.org/10.1186/1471-2407-8-361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613915/
https://www.ncbi.nlm.nih.gov/pubmed/19055847
http://dx.doi.org/10.1186/1471-2407-8-361

Ejemplares similares